Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study. Mullin K, Croop R, Mosher L, Fullerton T, et al. Cephalalgia 2024;44:3331024241259456.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mullin K, Croop R, Mosher L, Fullerton T, et al. Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study. Cephalalgia 2024;44:3331024241259456.
PMID: 39210835